Inventor · disambiguated record
Glenn Miller
Also filed as: MILLER GLENN · MILLER GLENN T
11 granted patents·7 pending applications·447 citations·filing 1992–2007
93Inventor score
Top patents by PatentIndex Score
18 records- 0195US7282484B2Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2006·Granted Oct 16, 2007·14 cites·12 claims
- 0294US7259138B2Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2005·Granted Aug 21, 2007·11 cites·10 claims
- 0394US6890904B1Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2000·Granted May 10, 2005·85 cites·64 claims
- 0493US6949514B2Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2003·Granted Sep 27, 2005·43 cites·52 claims
- 0593US6300314B1Hematopoietic stimulationPOINT THERAPEUTICS INC·Filed 1999·Granted Oct 9, 2001·106 cites·36 claims
- 0690US6770628B2Hematopoietic stimulationPOINT THERAPEUTICS INC·Filed 2001·Granted Aug 3, 2004·34 cites·21 claims
- 0790US5547853ACD2-binding domain of lymphocyte function associated antigen 3BIOGEN INC·Filed 1992·Granted Aug 20, 1996·66 cites·35 claims
- 0883US7067489B2Hematopoietic stimulationPOINT THERAPEUTICS INC·Filed 2004·Granted Jun 27, 2006·14 cites·16 claims
- 0976US5914111ACD2-binding domain of lymphocyte function associated antigen-3BIOGEN INC·Filed 1995·Granted Jun 22, 1999·30 cites·6 claims
- 1074US5928643AMethod of using CD2-binding domain of lymphocyte function associated antigen 3 to initiate T cell activationBIOGEN INC·Filed 1995·Granted Jul 27, 1999·24 cites·4 claims
- 1168US5728677AMethods of inhibiting T-cell dependent proliferation of peripheral blood lymphocytes using the CD2-binding domain of lymphocyte function associated antigen 3BIOGEN INC·Filed 1995·Granted Mar 17, 1998·20 cites·9 claims
- 1263US2008221068A1Anti-tumor agentsPOINT THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1361US2007072830A1Methods for treating diabetesPOINT THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1458US2007135354A1Hematopoietic stimulationPOINT THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1557US2006063719A1Methods for treating diabetesPOINT THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1649US2005084490A1Boroproline compound combination therapyPOINT THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 1749US2006094693A1Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditionsPOINT THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1849US2004077601A1Methods and compositions relating to isoleucine boroproline compoundsPOINT THERAPEUTICS INC·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →